The Schilling test is used to determine whether the body absorbs vitamin B12 normally.
Vitamin B12 absorption test
How the test is performed
This test may be performed in four different stages to find the cause of low vitamin B12 levels.
Stage I: You will get two doses of vitamin B12 (cobalamin). You will take a small, first dose (a radioactive form of B12) by mouth. You will a second, larger dose by a shot 1 hour later. You will need to collect your urine over the next 24 hours, and deliver it to a lab or your doctor's office. The urine will be checked to see if you are absorbing vitamin B12 normally. For information on collecting the urine sample, see: 24-hour urine collection
If Stage I is abnormal, Stage II may be done 3 - 7 days later.
Stage II: You are given radioactive B12 along with intrinsic factor. Intrinsic factor is a protein produced by cells in the stomach lining. The body needs it so the intestines can absorb vitamin B12 efficiently.
Stage II of the test can tell whether low vitamin B12 levels are caused by problems in the stomach that prevent it from producing intrinsic factor.
If a Stage II test is abnormal, a Stage III test is performed.
Stage III: This test is done after you have taken antibiotics for 2 weeks. It can tell whether abnormal bacterial growth has caused the low vitamin B12 levels.
Stage IV: This test determines whether low vitamin B12 levels are caused by problems with the pancreas. With this test, you will take pancreatic enzymes for three days, followed by a radioactive dose of vitamin B12.
How to prepare for the test
Do not eat for 8 hours before starting the test, then eat normally for the next 24 hours. You can drink water.
The health care provider may ask you to stop taking drugs that can affect the test.
You cannot have intramuscular injection B12 within 3 days before the test.
How the test will feel
The injection of vitamin B12 may sting.
Why the test is performed
The Schilling test is performed to check vitamin B12 absorption and to evaluate patients for pernicious anemia.
Additional conditions under which the test may be performed:
Antony AC. Megaloblastic Anemias. In: Hoffman R, Benz EJ, Shattil SS, et al, eds. Hematology: Basic Principles and Practice. 5th ed. Philadelphia, Pa: Elsevier Churchill Livingstone; 2008:chap 39.
Todd Gersten, MD, Hematology/Oncology, Palm Beach Cancer Institute, West Palm Beach, FL. Review provided by VeriMed Healthcare Network. Also reviewed by Linda J. Vorvick, MD, Medical Director and Director of Didactic Curriculum, MEDEX Northwest Division of Physician Assistant Studies, Department of Family Medicine, UW Medicine, School of Medicine, University of Washington; David Zieve, MD, MHA, Medical Director, A.D.A.M., Inc.
are leaving the St. Francis Health Center/Sisters of Charity of Leavenworth
Health System website. Persons visiting this external site assume full
responsibility for use of its information and agree that St. Francis/SCLHS is
not responsible or liable for claim, loss/damage arising from this use or for
the content of any external site. Your use of any external site is subject to
our full disclaimer.